Literature DB >> 16794193

The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases.

Andreas S Barth, Joshua M Hare.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16794193     DOI： 10.1161/01.RES.0000231257.15059.d7

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  5 in total

Review 1.  Cardiovascular genetic medicine: genomic assessment of prognosis and diagnosis in patients with cardiomyopathy and heart failure.

Authors:  Bettina Heidecker; Joshua M Hare
Journal:  J Cardiovasc Transl Res       Date:  2008-08-02       Impact factor: 4.132

2.  Transcriptomic biomarkers for individual risk assessment in new-onset heart failure.

Authors:  Bettina Heidecker; Edward K Kasper; Ilan S Wittstein; Hunter C Champion; Elayne Breton; Stuart D Russell; Michelle M Kittleson; Kenneth L Baughman; Joshua M Hare
Journal:  Circulation       Date:  2008-06-30       Impact factor: 29.690

3.  Genomic and proteomic determinants of lower extremity revascularization failure: rationale and study design.

Authors:  Peter R Nelson; Kerri A O'Malley; Robert J Feezor; Lyle L Moldawer; James M Seeger
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

Review 4.  The use of transcriptomic biomarkers for personalized medicine.

Authors:  Bettina Heidecker; Joshua M Hare
Journal:  Heart Fail Rev       Date:  2007-03-28       Impact factor: 4.654

Review 5.  Genetic basis of atrial fibrillation.

Authors:  Oscar Campuzano; Alexandra Perez-Serra; Anna Iglesias; Ramon Brugada
Journal:  Genes Dis       Date:  2016-09-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.